| 000 | 01867 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250517061037.0 | ||
| 264 | 0 | _c20161024 | |
| 008 | 201610s 0 0 eng d | ||
| 022 | _a1573-904X | ||
| 024 | 7 |
_a10.1007/s11095-015-1812-1 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGe, Shufan | |
| 245 | 0 | 0 |
_aCurcumin Affects Phase II Disposition of Resveratrol Through Inhibiting Efflux Transporters MRP2 and BCRP. _h[electronic resource] |
| 260 |
_bPharmaceutical research _cMar 2016 |
||
| 300 |
_a590-602 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 | _aATP Binding Cassette Transporter, Subfamily G, Member 2 |
| 650 | 0 | 4 |
_aATP-Binding Cassette Transporters _xantagonists & inhibitors |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 | _aCell Line, Transformed |
| 650 | 0 | 4 |
_aCurcumin _xpharmacology |
| 650 | 0 | 4 | _aDogs |
| 650 | 0 | 4 |
_aGlucuronides _xmetabolism |
| 650 | 0 | 4 |
_aGlucuronosyltransferase _xmetabolism |
| 650 | 0 | 4 | _aHeLa Cells |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMadin Darby Canine Kidney Cells |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMembrane Transport Proteins |
| 650 | 0 | 4 |
_aMetabolic Detoxication, Phase II _xphysiology |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Knockout |
| 650 | 0 | 4 | _aMultidrug Resistance-Associated Protein 2 |
| 650 | 0 | 4 |
_aMultidrug Resistance-Associated Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aNeoplasm Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 | _aResveratrol |
| 650 | 0 | 4 |
_aStilbenes _xmetabolism |
| 650 | 0 | 4 | _aUDP-Glucuronosyltransferase 1A9 |
| 700 | 1 | _aYin, Taijun | |
| 700 | 1 | _aXu, Beibei | |
| 700 | 1 | _aGao, Song | |
| 700 | 1 | _aHu, Ming | |
| 773 | 0 |
_tPharmaceutical research _gvol. 33 _gno. 3 _gp. 590-602 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s11095-015-1812-1 _zAvailable from publisher's website |
| 999 |
_c25388809 _d25388809 |
||